Neutrophil-lymphocyte ratio and the risk of 30-day mortality in patients with overt hepatic encephalopathy

被引:3
作者
Shi, Ke [1 ]
Huang, Yunyi [2 ]
Zhang, Qun [1 ]
Li, Yuxin [1 ]
Wang, Xianbo [1 ]
机构
[1] Capital Med Univ, Beijing Ditan Hosp, Ctr Integrat Med, Beijing 100015, Peoples R China
[2] Nanyang Cent Hosp, Tradit Chinese Med Dept, Nanyang, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
inflammation; hepatic encephalopathy; neutrophil-to-lymphocyte ratio; prognosis; STAGE LIVER-DISEASE; PROGNOSTIC VALUE; CIRRHOSIS; MODEL; PATHOGENESIS; DYSFUNCTION; NOMOGRAM; SURVIVAL;
D O I
10.1097/MEG.0000000000002368
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Patients with overt hepatic encephalopathy (OHE) have an increased risk of adverse outcomes. However, the relationship between neutrophil to lymphocyte ratio (NLR) and the 30-day risk of death in patients with OHE has not been well evaluated. Methods We retrospectively analyzed 1301 patients with OHE at Beijing Ditan Hospital between August 2008 and December 2018. After adjustment for major risk factors, Cox regression analysis and restricted cubic splines were used to analyze the relation between NLR and 30-day mortality. The 30-day survival was calculated by Kaplan-Meier method. Results All patients were divided into four subgroups on the basis of the quartiles of the baseline NLR distribution (< 2.5, 2.5-4.3, 4.3-7.5, >7.5). The 30-day mortality rates were 7.8%, 12.7%, 19.5% and 34.1%, respectively (P < 0.001). Compared with the lowest quartile, the increase in the NLR was associated with an increase risk of 30-day mortality after multivariable adjustment (NLR 2.5-4.3: adjusted hazard ratio [AHR], 1.17 (95% confidence interval [CI], 0.70-1.95); NLR 4.3-7.5: AHR, 1.58 (95% CI, 1.01-2.47); NLR > 7.5: AHR, 2.32 (95% CI, 1.50-3.57). A nonlinear association between NLR and the adjusted probability of 30-day mortality was observed. Elevated NLR was correlated with increased 30-day mortality in patients with OHE across different subgroups (HR >1.0). Conclusion An elevated NLR is independently associated with a higher risk of 30-day mortality in patients with OHE.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 32 条
  • [1] Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
    Albillos, Agustin
    Lario, Margaret
    Alvarez-Mon, Melchor
    [J]. JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1385 - 1396
  • [2] Pathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation
    Aldridge, Dominic R.
    Tranah, Edward J.
    Shawcross, Debbie L.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 : S7 - S20
  • [3] Hepatic encephalopathy: Diagnosis and management
    Amodio, Piero
    [J]. LIVER INTERNATIONAL, 2018, 38 (06) : 966 - 975
  • [4] Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures
    Bajaj, Jasmohan S.
    O'Leary, Jacqueline G.
    Tandon, Puneeta
    Wong, Florence
    Garcia-Tsao, Guadalupe
    Kamath, Patrick S.
    Maliakkal, Benedict
    Biggins, Scott W.
    Thuluvath, Paul J.
    Fallon, Michael B.
    Subramanian, Ram M.
    Vargas, Hugo E.
    Lai, Jennifer
    Thacker, Leroy R.
    Reddy, K. Rajender
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (04) : 565 - +
  • [5] The 3-Month Readmission Rate Remains Unacceptably High in a Large North American Cohort of Patients With Cirrhosis
    Bajaj, Jasmohan S.
    Reddy, K. Rajender
    Tandon, Puneeta
    Wong, Florence
    Kamath, Patrick S.
    Garcia-Tsao, Guadalupe
    Maliakkal, Benedict
    Biggins, Scott W.
    Thuluvath, Paul J.
    Fallon, Michael B.
    Subramanian, Ram M.
    Vargas, Hugo
    Thacker, Leroy R.
    O'Leary, Jacqueline G.
    [J]. HEPATOLOGY, 2016, 64 (01) : 200 - 208
  • [6] Prognostic significance of hepatic encephalopathy in patients with cirrhosis
    Bustamante, J
    Rimola, A
    Ventura, PJ
    Navasa, M
    Cirera, I
    Reggiardo, V
    Rodés, J
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 890 - 895
  • [7] A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure
    Cai, Y. -J.
    Dong, J. -J.
    Dong, J. -Z.
    Chen, Y.
    Lin, Z.
    Song, M.
    Wang, Y. -Q.
    Chen, Y. -P.
    Shi, K. -Q.
    Zhou, M. -T.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1413 - 1426
  • [8] CONN HO, 1977, GASTROENTEROLOGY, V72, P573
  • [9] Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis
    Dirchwolf, Melisa
    Eduardo Ruf, Andres
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (16) : 1974 - 1981
  • [10] FLEXIBLE REGRESSION-MODELS WITH CUBIC-SPLINES
    DURRLEMAN, S
    SIMON, R
    [J]. STATISTICS IN MEDICINE, 1989, 8 (05) : 551 - 561